Nosocomial pneumonia, or hospital-acquired pneumonia (HAP), and ventilator-associated
pneumonia (VAP) are important health problems worldwide, with both being associated with …

Introduction Nosocomial pneumonia develops after≥ 48 h of hospitalisation and is
classified as ventilator-associated pneumonia (VAP) and hospital-acquired pneumonia …

Hospital-acquired pneumonia and ventilator-associated pneumo... : Current Opinion in
Pulmonary Medicine Hospital-acquired pneumonia and ventilator-associated pneumonia …

Hospital-acquired pneumonia (HAP) and its subtype, ventilator-associated pneumonia
(VAP), remain two significant causes of morbidity and mortality worldwide, despite the better …

As ventilator-associated pneumonia increases, empiric therapy should be based on local
pathogen etiology and antibiotic resistant patterns. A new approach to consider is to start …

Nosocomial pneumonia complicates the course of a large number of hospitalized patients,
associated with a higher risk of death, prolonged length of stay and over-costs. Rates of …

In accordance with the recommendations of, amongst others, the Surviving Sepsis
Campaign and the recently published European treatment guidelines for hospital-acquired …

Hospital-associated pneumonia (HAP) is one of the most common infections acquired
among hospitalized patients. HAP is associated with excess mortality and increased medical …

The American Thoracic Society (ATS) guideline for hospital-acquired pneumonia (HAP)
released in 1996 and the Trouillet classification published in 1998 supply different rational …

The appropriate management and prevention of hospital-acquired pneumonia (HAP) remain
major medical challenges. Much work has been done in this field in the last two decades …